Skip to content
PICO Portalanswers from OpenAlex

MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway

PaperCitations, authors & open-access status

MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway is a paper indexed in PICO Portal from OpenAlex.

How many citations does MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway have?

PICO Portalcitation count

MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway has 76 citations in the OpenAlex counts PICO Portal stores.

When was MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway published?

PICO Portalyear

MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway has 2019 year in the PICO Portal index.

What is the open-access status of MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway?

PICO Portaloa status

MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway has closed oa status in the PICO Portal index.

What is the DOI of MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway?

PICO Portaldoi

The DOI for MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway is on the source record.

What is the PMID of MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway?

PICO Portalpmid

The PMID for MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway is on the source record.

What is the OpenAlex record for MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway?

PICO Portalopenalex

The OpenAlex for MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial